Idioma:

ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2

Influenza and other respiratory viruses, 2021-09, Vol.15 (5), p.561-568 [Periódico revisado por pares]

Chichester: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2
Assuntos: Antibodies ; Asymptomatic ; Bias ; Coronaviruses ; COVID-19 vaccines ; Disease transmission ; Diseases ; emerging ; Epidemics ; Epidemiology ; Health aspects ; Heterogeneity ; Households ; Hypotheses ; Illnesses ; Immunoassay ; Immunology ; Infections ; Infectious diseases ; Influenza ; Longitudinal studies ; Medical research ; Medicine, Experimental ; Pathogens ; Population ; Population studies ; Prevalence studies (Epidemiology) ; Public health ; Respiratory diseases ; SARS‐CoV‐2 ; seroepidemiologic Studies ; Serology ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Short Communication ; Short Communications ; Surveillance ; Viral antibodies ; Viral diseases ; Viruses
É parte de: Influenza and other respiratory viruses, 2021-09, Vol.15 (5), p.561-568
Notas: Funding information
See Appendix 1 for World Health Organization Seroepidemiology Technical Working Group.
The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not‐for‐profit sectors
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Well‐designed population‐based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS‐CoV‐2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES‐S: Reporting of Seroepidemiologic studies—SARS‐CoV‐2. This is an updated checklist of 22 items that should be included in the reporting of all SARS‐CoV‐2 seroepidemiologic studies, irrespective of study design.
Editor: Chichester: John Wiley & Sons, Inc
Idioma: Inglês

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2

Chichester: John Wiley & Sons, Inc

Buscando em bases de dados remotas. Favor aguardar.